Skip to main navigation Skip to search Skip to main content

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma

  • Christopher L. Moertel
  • , Angela C. Hirbe
  • , Hans H. Shuhaiber
  • , Kevin Bielamowicz
  • , Alpa Sidhu
  • , David Viskochil
  • , Michael D. Weber
  • , Armend Lokku
  • , L. Mary Smith
  • , Nicholas K. Foreman
  • , Fouad M. Hajjar
  • , Rene Y. McNall-Knapp
  • , Lauren Weintraub
  • , Reuben Antony
  • , Andrea T. Franson
  • , Julia Meade
  • , David Schiff
  • , Tobias Walbert
  • , Prakash Ambady
  • , Daniela A. Bota
    • Cynthia J. Campen, Gurcharanjeet Kaur, Laura J. Klesse, Stefania Maraka, Paul L. Moots, Kathryn Nevel, Miriam Bornhorst, Ana Aguilar-Bonilla, Sarah Chagnon, Nagma Dalvi, Punita Gupta, Ziad Khatib, Laura K. Metrock, P. Leia Nghiemphu, Ryan D. Roberts, Nathan J. Robison, Zsila Sadighi, Stacie Stapleton, Dusica Babovic-Vuksanovic, Timothy R. Gershon

Research output: Contribution to journal › Article › peer-review

82   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science